HVTN Research and Mentorship Program (RAMP) Scholar Program for African-American and Latinx Medical Students
Applications for 2017-2018 have closed. Please check the site in September 2018 for information on the next round of applications, or email Jenna Udren, RAMP Project Manager (firstname.lastname@example.org) to be notified when applications are open.
The HIV Vaccine Trials Network, in collaboration with the National Institute of Mental Health and the National Institute of Allergy and Infectious Diseases, is investing in the next generation of HIV prevention researchers by providing African American and Latinx medical students with opportunities to conduct independent research while receiving mentoring, project and salary funding, training, and professional development opportunities.
Grant recipients will work under the mentorship of HVTN-affiliated investigators to conduct research projects in areas of basic, clinical, behavioral, laboratory and social science. Projects can be:
Short-Term: 2-4 months
- Can be timed with a summer break or fourth year research elective
- Travel to an HIV Vaccine Clinical Research Site in the US or abroad
- Attend and present at an HVTN Conference
- Maximum award of $20,000 (8-10 weeks)
- Maximum award of $25,000 (>10 weeks-16 weeks)
Long-Term: 9-12 months
- Research at an HIV Vaccine Trials Clinical Research Site in the US with up to 16 weeks at an international HIV Vaccine Trials Unit
- Can be timed with a planned Master's or doctoral program, or be a distinct, non-degree associated research-focused year
- Attend two scientific conferences, including presenting at the HVTN conference
- Maximum award of $70,000
RAMP scholars are funded to travel to an HVTN Clinical Research Site to conduct a project under the mentorship of an investigator.
Past projects include, but are not limited to:
- Effectiveness of social media to engage young African-American and Latino men who have sex with men to participate in HIV prevention research
- Development of Robust Assays That Identify Functional and Phenotypical Immune Correlates for HIV-1 Vaccine Optimization
- Female-to-Male (FTM) Transgender Individuals: Assessing knowledge of HIV vaccines and biomedical prevention methods, barriers and facilitators to participation in vaccine trials
- Zimbabwean Health Practicioners' Knowledge of and Attitudes towards HIV Vaccines and VISP
Who can apply?
The HVTN will be accepting up to 8 RAMP scholars who meet the following criteria:
- Self-identify as African-American and/or Latinx
- Student at US medical school
- In good academic standing
- US citizen or US permanent resident
- Interested in pursuing a future career in HIV research
Application materials will be posted in Fall 2018.
For more information, please contact:
Jenna Udren, MPH
RAMP Project Manager
HIV Vaccine Trials Network
Fred Hutchinson Cancer Research Center
1100 Eastlake Ave., E3-300
Seattle, WA 98109-1024
Office: (206) 667-6712